Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients

by Paul Armentano, NORML Deputy Director
Posted on August 18, 2014

The administration of a single dose of whole-plant cannabis via a thermal-metered inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy.

SOCIETY

Study: Oral THC Safely and Effectively Addresses Post-Traumatic Stress Symptoms

by Paul Armentano, NORML Deputy Director
Posted on June 18, 2014

The administration of oral THC mitigates symptoms of post-traumatic stress syndrome (PTSD), according to clinical trial data published online ahead of print in the journal Clinical Drug Investigation. Researchers reported, “The intervention caused a statistically significant improvement in global symptom severity, sleep quality, frequency of nightmares, and PTSD hyperarousal symptoms.” They concluded, “Orally absorbable delta-9-THC was safe and well tolerated by patients with chronic PTSD.”

SCIENCE

Study: Inhaled Cannabis Mitigates Parkinson’s Disease Symptoms

by Paul Armentano, NORML Deputy Director
Posted on March 17, 2014

Inhaling whole-plant cannabis provides symptomatic relief in patients with Parkinson’s disease (PD), according to observational trial data published in the March/April edition of the journal Clinical Neuropharmacology. Researchers reported that inhaled cannabis was associated with “significant improvement after treatment in tremor, rigidity, and bradykinsea (slowness of movement). There was also significant improvement of sleep and pain scores. No significant adverse effects of the drug were observed.”

ACTIVISM

Study: Inhaled Cannabis Reduces Crohn’s Symptoms

by Paul Armentano, NORML Deputy Director
Posted on May 13, 2013

Inhaling cannabis reduces symptoms of Crohn’s disease compared to placebo in patients non-responsive to traditional therapies, according to clinical trial data published online ahead of print in the journal Clinical Gastroenterology and Hepatology. The study is the first placebo-controlled clinical trial to assess the consumption of cannabis for the treatment of Crohn’s.